{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:50:37Z","timestamp":1792169437469,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.arth.2026.10.008","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:08:52Z","timestamp":1792166932000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative Selective Serotonin Reuptake Inhibitor Use is Associated With Increased Complication Risk After Total Hip Arthroplasty: A Dose-Response Analysis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9100-9948","authenticated-orcid":false,"given":"Samuel P.","family":"Alfonsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Zickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya S.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Bailey","family":"Terhune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.arth.2026.10.008_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.arth.2021.11.013","article-title":"Effects of perioperative selective serotonin reuptake inhibitor use in primary total hip and knee arthroplasty","volume":"37","author":"Bourget-Murray","year":"2022","journal-title":"J Arthroplasty"},{"issue":"6","key":"10.1016\/j.arth.2026.10.008_bib2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s11999.0000000000000098","article-title":"Perioperative inpatient use of selective serotonin reuptake inhibitors is associated with a reduced risk of THA and TKA revision","volume":"476","author":"Yao","year":"2018","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"10.1016\/j.arth.2026.10.008_bib3","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.5435\/JAAOS-D-23-00459","article-title":"Treatment of concurrent depression and its effect on outcomes after total joint arthroplasty: a systematic review of comparative studies","volume":"32","author":"Morgan","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"issue":"12","key":"10.1016\/j.arth.2026.10.008_bib4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jamainternmed.2013.714","article-title":"Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery","volume":"173","author":"Auerbach","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.arth.2026.10.008_bib5","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.arth.2019.04.057","article-title":"Perioperative selective serotonin reuptake inhibitor use is associated with an increased risk of transfusion in total hip and knee arthroplasty","volume":"34","author":"Belay","year":"2019","journal-title":"J Arthroplasty"},{"issue":"8","key":"10.1016\/j.arth.2026.10.008_bib6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/10600280221134108","article-title":"Evaluation of bleeding in orthopedic surgery with perioperative use of serotonergic antidepressants","volume":"57","author":"Yang","year":"2023","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.arth.2026.10.008_bib7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/JCP.0000000000000575","article-title":"Selective serotonin reuptake inhibitors and operative bleeding risk: a review of the literature","volume":"36","author":"Roose","year":"2016","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.arth.2026.10.008_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bone.2012.05.018","article-title":"Antidepressant medications and osteoporosis","volume":"51","author":"Rizzoli","year":"2012","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.arth.2026.10.008_bib9","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00198-018-4413-0","article-title":"Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis","volume":"29","author":"Zhou","year":"2018","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.arth.2026.10.008_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biopsych.2012.11.003","article-title":"Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function","volume":"74","author":"Hodge","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.arth.2026.10.008_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.psychres.2019.04.006","article-title":"Effect of selective serotonin reuptake inhibitors on markers of bone loss","volume":"276","author":"Kumar","year":"2019","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.arth.2026.10.008_bib12","article-title":"Use of serotonin reuptake inhibitors and risk of subsequent bone loss in a nationwide population-based cohort study","volume":"11","author":"Kang","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.arth.2026.10.008_bib13","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jbmr.1554","article-title":"Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis","volume":"27","author":"Eom","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.arth.2026.10.008_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/jbmr\/zjaf106","article-title":"The risk of fracture among women starting selective serotonin reuptake inhibitors","author":"Solomon","year":"2025","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.arth.2026.10.008_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12020-014-0357-0","article-title":"Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome","volume":"48","author":"Bruy\u00e8re","year":"2015","journal-title":"Endocrine"},{"issue":"12","key":"10.1016\/j.arth.2026.10.008_bib16","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jamapsychiatry.2019.2859","article-title":"Association of antidepressant use with adverse health outcomes: a systematic umbrella review","volume":"76","author":"Dragioti","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.arth.2026.10.008_bib17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/trf.13992","article-title":"Psychopharmacologic treatment and blood transfusion in fast-track total hip and knee arthroplasty","volume":"57","author":"Gylvin","year":"2017","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.arth.2026.10.008_bib18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/ALN.0000000000000632","article-title":"Psychiatric disorders and psychopharmacologic treatment as risk factors in elective fast-track total hip and knee arthroplasty","volume":"123","author":"J\u00f8rgensen","year":"2015","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.arth.2026.10.008_bib19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/CORR.0000000000002481","article-title":"What is the association between clinically diagnosed psychiatric illness and total joint arthroplasty? A systematic review evaluating outcomes, healthcare use, and patient-reported outcome measures","volume":"481","author":"Hecht","year":"2023","journal-title":"Clin Orthop Relat Res"},{"issue":"25","key":"10.1016\/j.arth.2026.10.008_bib20","article-title":"Association between mental health conditions and revision rates in patients undergoing total hip and knee arthroplasty: a systematic review and meta-analysis","volume":"S0883-5403","author":"Smith","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2026.10.008_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s00264-025-06593-2","article-title":"Neurologic and psychiatric disorders as risk factors following hip arthroplasty: results from the German Arthroplasty Registry","author":"Wagener","year":"2025","journal-title":"Int Orthop"},{"issue":"5","key":"10.1016\/j.arth.2026.10.008_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/17453674.2016.1216181","article-title":"Is the use of antidepressants associated with patient-reported outcomes following total hip replacement surgery?","volume":"87","author":"Greene","year":"2016","journal-title":"Acta Orthop"},{"issue":"1","key":"10.1016\/j.arth.2026.10.008_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/bcpt.14017","article-title":"Psychopharmacological treatment in patients planned for hip or knee replacement","volume":"135","author":"Kornvig","year":"2024","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540326010739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540326010739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:08:57Z","timestamp":1792166937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540326010739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"alternative-id":["S0883540326010739"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2026.10.008","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Selective Serotonin Reuptake Inhibitor Use is Associated With Increased Complication Risk After Total Hip Arthroplasty: A Dose-Response Analysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2026.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}